RE: intersting news Wonderful news...with FDA approval still not officially finalized adding Dr. Solomon would indicate we are perhaps well on our way.
Favorite quote of the NR:
"The PreVu Non-Invasive Skin Cholesterol Test is a remarkable new risk assessment technology to assist in the earlier detection and primary prevention of coronary artery disease. It provides further risk stratification against the traditional determination of 'global risk', and can consequently help better identify patients with subclinical cardiovascular disease who could benefit from more intensive primary prevention measures to prevent a first coronary event."
All the best
Stockington